Mallinckrodt plc (MNK) will report fourth quarter results on November 7, 2013. The company will hold a conference call for investors beginning at 8:30am/U.S. Eastern Daylight Time. The call can be accessed in three ways.
- At the Mallinckrodt website: http://mallinckrodt.com/investor_relations.aspx
- By telephone: For both “listen-only” participants and those who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. 877-703- 6107 For participants outside the U.S., the dial-in number is 857-244-7306. The access code for all callers is 20619575
- Through an audio replay: A replay of the call will be available beginning at 12:30pm/U.S. Eastern Daylight Time on November 7, 2013, and ending at 12:59pm/U.S. Eastern Daylight Time on November 14, 2013. The dial-in number for U.S. participants is 888-286-8010. For participants outside the U.S., the replay dial-in number is 617- 801-6888. The replay access code for all callers is 67136812.
Mallinckrodt is a leading global specialty pharmaceuticals business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company’s Specialty Pharmaceuticals segment includes branded and generic drugs, and the Global Medical Imaging segment includes contrast media and nuclear imaging agents. Mallinckrodt has approximately 5,500 employees worldwide with sales in roughly 70 countries. The company’s 2012 revenue totaled $2.1 billion. To learn more about Mallinckrodt, visit www.mallinckrodt.com.
- Investment & Company Information